Digital Pills Market 2025: Here’s What Expert Say (Product Type, Applications, Revenue, Opportunities, Players, Regions)

Market Synopsis
Digital pills are swallowable medication embedded with sensor about the size of grain of sand that tracks data when patients take their medicine. Theses sensors are connected to some sort of external devices such as mobiles, smart phones or wearable skin patches and can travel safely through the gastrointestinal tract. As drugs are taken these external devices are conveyed with the data to doctors or physicians evaluating whether and when patients take their medicine.

The technology aim at provide health practitioners with a tracking system (GPS) of sorts for the human body so that they can chase patient's compliance with their routine. Another major purpose of these medicines or pills is to better tailor or personalized medicine as per the patient’s requirement. These digital drugs are also anticipated to solve couple of problems faced by pharmaceutical companies and insurers, which includes lower drug sales due to missed doses and higher medical costs handling patients whose conditions worsen. Recently in November 2017 FDA approved first digital pill for the treatment of schizophrenia and depression in adults by Otsuka Pharmaceuticals.

Technological advancements in tracking systems and tools reduced expenses from wasted medicines, high prevalence of chronic disease, faster recovery time due to greater better adherence to treatment regimens and proposed for use in susceptible patient group are some of the major factors driving the growth of the global digital pills market. Increasing prevalence of disease such as diabetes and other cardiovascular disorders and need for controlled dosage delivery are some of the other major driving factors leading to the market growth.

Request for a sample copy of this report @ http://bit.ly/2w0tHrA

Segmentation
Global digital pills market has been segmented on the basis of disease and end-user. Based on the type of disease market is divided as infectious diseases, cardiovascular disease, diabetes and other disease. Cardiovascular disease segment comprises the largest market share due to the increasing risk and prevalence of heart and cardiovascular diseases. Based on end user, the market is further segmented as clinics, hospitals and homecare settings.

Regional Analysis
The market has been segmented into four major geographies such as North America, Europe, Asia Pacific and Latin America and Middle East and Africa. North America with the recent approval of certain digital pills commands the maximum market share. The emerging or growing economics such as Middle East countries, Africa, and Asia-Pacific nations, are the upcoming driving factors for the digital pills technology market due to increasing healthcare awareness, their growing GDP, and rising demand for advanced treatments for diseases such as diabetes. Also, Countries such as Japan due to high prevalence of target diseases, together with growing government support is expected to create new opportunities for the digital pills market.

View Full Report @ http://bit.ly/2MrHOjZ

Key Questions answered:
• What will the market growth rate, Overview and Analysis of Global digital pills Market over the forecast period from 2017 to 2025?
• What are the key factors driving the growth of the market, Analysis by Applications and Countries engaged in Global digital pills Market?
• What are the Opportunities, trends, Risk and threats Faced by the vendors in Global digital pills Market?
• What are the challenges to encounter by key vendors in the global digital pills market growth?
• Deep analysis of top key players in the market and what are their strategies to expand digital pills market globally?
• What is the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• Macroeconomic factors affecting the growth of the digital pills market and what are the key outcomes of the five forces analysis of the global digital pills market?

Major key Players profiled in the market include: 2morrow Inc., Abbott, Alivecor Inc, Irhythm technologies, Livongo health, Novartis Ag, Omada health, Inc., Otsuka America pharmaceutical, Inc., Proteus digital health, Inc. and Welldoc, Inc.

About Us:
We at Garner Insights.com provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.

Contact Us:
Kevin Thomas
Contact No: +1 513 549 5911 (US)
+44 203 318 2846 (UK)
Email: sales@garnerinsights.com

This release was published on openPR.